𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy

✍ Scribed by Ji H Kim; Sang K Yu; Yeon S Seo; Hyung J Yim; Jong E Yeon; Jong J Park; Jae S Kim; Young T Bak; Chang H Lee; Kwan S Byun

Book ID
108951377
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
231 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Hepatitis B infection of the liver in ch
Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum
✍ Luisa Fernanda Mariscal; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Cas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

## Abstract Hepatitis B virus (HBV) DNA may persist in the liver in the absence of serum HBV–DNA after a self‐limited acute hepatitis B. This may also occur in patients with chronic hepatitis C virus (HCV) infection but its prevalence and its impact on liver histology is unknown. HBV–DNA was tested

Patterns of circulating hepatitis B viru
Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy
✍ Wei Zhang; Hans Jörg Hacker; Mehmet Tokus; Thomas Bock; Claus H. Schröder 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract We examined whether lamivudine treatment, in addition to the rapid decline of HBV serum DNA described in a large number of laboratories, causes changes in composition and amount of discernable circulating viral DNA and RNA. Nucleic acids were extracted from serial serum samples of a pat